SIGA Technologies' IPO

SIGA Technologies raised a round of funding on September 11, 1997. Investors include Public.

SIGA designs and develops novel countermeasures to prevent and treat serious infectious diseases, with an emphasis on biological warfare defense. SIGAs leading program is ST-246®, an oral therapeu…

Articles about SIGA Technologies' IPO: